News

Shoals’s (NASDAQ:SHLS) Q4 Sales Top Estimates But Stock Drops

Solar energy systems company Shoals (NASDAQ:SHLS) announced better-than-expected revenue in Q4 CY2024, but sales fell by 18% year on year to $107 million. On the other hand, next quarter’s revenue guidance of $75 million was less impressive, coming in 25% below analysts’ estimates. Its non-GAAP profit of $0.08 per share was 16.7% below analysts’ consensus estimates.

AdaptHealth (NASDAQ:AHCO) Posts Better-Than-Expected Sales In Q4, Stock Soars

Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales were flat year on year at $856.6 million. On the other hand, the company’s full-year revenue guidance of $3.29 billion at the midpoint came in 1.2% below analysts’ estimates. Its GAAP profit of $0.34 per share was 34.8% above analysts’ consensus estimates.

Novanta (NASDAQ:NOVT) Misses Q4 Sales Targets

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 12.5% year on year to $238.1 million. Next quarter’s revenue guidance of $234 million underwhelmed, coming in 4.4% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 6.5% above analysts’ consensus estimates.